Endocrinology Flashcards

1
Q

Causes of secondary diabetes

A

Pancreatic disorders:
*Chronic pancreatitis

Endocrine disorders:
*Cushing syndrome
*Acromegaly *Phaeochromocytoma
*Polycystic ovarian syndrome
*Haemochromatosis

Drug-induced diabetes (transient):
*Thiazide diuretics
*Corticosteroids
*Oestrogen therapy (high dose—not with low-dose HRT)

Other transient causes
*Gestational diabetes
*Medical or Surgical stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

neonate blood glucose level of <2.6 mmol/L

A

childhood hypoglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

childhood hypoglycaemia treatment

A

IV dextrose 10%, 2.5 to 5 mL/Kg followed by 0.03 to 0.05 mL/Kg/minute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adult hypoglycaemia treatment

A

IV dextrose 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hypoglycaemia risk factors

A

– Alcohol abuse-suppression of gluconeogenesis.
– Liver failure.
– Cognitive impairment.
– Increasing age
– Previous history of hypoglycaemia.
– Vigorous and prolonged exercise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DM (type 2) Screening

A

*People with known impaired fasting glucose/glucose tolerance (‘prediabetes’)
(FBS yearly for this scenario)

*Age >40 years

*>30 years: 1st degree relative with T2D), BMI >30), high-prevalence ethnic groups

*Age >18 years in Aboriginal and Torres Strait Islanders

*Previous GDM

*People on long-term steroids or antipsychotics

*PCOS, especially if overweight

*Previous cardiovascular event

The optimal frequency is every 3 years from age 40 years using AUSDRISK

If the score is ≥12, do fasting blood glucose or HbA1c.

Screen annually in very high-risk groups:
*Aboriginal and Torres Strait Islander people
*Prediabetes pacients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnosis DM in Symptomatic

A

At least two of: Polydipsia, polyuria, frequent skin infections or frequent genital thrush

Skin signs of diabetes:
a) Recurrent staphylococcus folliculitis
b) Candida albicans erosio interdigitalis
c) Candida albicans balanitis.

Fasting venous blood glucose (VBG) ≥7.0 mmol/L

or

Random VBG (at least 2 hours after last eating) ≥11.1 mmol/L

or

HbAIc >6.5% (>48 mmol/mol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagnosis DM in Asymptomatic

A

At least two separate elevated values: Either fasting (≥7.0 mmol/L), 2 or more hours postprandial (≥11.1 mmol/L)

or

Two altered values from an oral glucose tolerance test (OGTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

OGTT

A

The 2-hour blood sugar on an OGTT is still the gold standard for the diagnosis of uncertain diabetes >11.1 mmol/L.

If random or fasting VBG lies in an uncertain range (5.5–11.0 mmol/L) in either a symptomatic patient or a patient with risk factors (over 50 years, overweight, first-degree relative with T2D), perform an OGTT. The cut-off point for further testing is 5.5 mmol/L.

The OGTT should be reserved for true borderline cases and for diagnosing gestational diabetes, where a 75 mg OGTT is recommended at 24–28 weeks gestation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CV risk assessment

A

every 2 yrs after 45yrs
>35yrs for aboriginals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diabetic ketoacidosis: Clinical features

A

Develops over a few days, but may occur in a few hours in ‘brittle’ diabetics

Hyperglycaemia (often >20 mmol/L, lower or normal if on SGLT2 inhibitor)

Preceded by polyuria, polydipsia, drowsiness

Vomiting and abdominal pain, dehydration

Hyperventilation—severe acidosis (acidotic breathing): ↓BP, ↑pulse, ↑resp. rate

Ketosis (blood and urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diabetic retinopathy ophthalmic referral

A

low risk: 2 yearly
high risk: yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diabetic ketoacidosis: Management

A

Early IV fluids—normal saline fast first litre, then caution

IV insulin—slow, e.g. 10 U in first hour

ECG—arrhythmia in electrolyte disturbances

Diabetic ketoacidosis with coma: Fluids, sodium (3 L N saline), potassium (KCl) and insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hyperosmolar hyperglycaemia: Clinical features

A

Marked hyperglycaemia and dehydration without ketoacidosis.

Altered conscious state varying from stupor to coma and with marked dehydration.

The onset may be insidious over a period of weeks, with fatigue, polyuria and polydipsia.

Typically in uncontrolled type 2 diabetes, especially in elderly patients.

There may be evidence of an underlying disorder such as pneumonia or a urinary infection.

Extreme hyperglycaemia and high plasma osmolarity.

The condition has a high mortality—even higher than ketoacidosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hyperosmolar hyperglycaemia: Treatment

A

IV fluids, e.g. normal to 1⁄2 normal saline, given slowly

Insulin—relatively lower doses than acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lactic acidosis: Clinical features

A

Marked hyperventilation ‘air hunger’ and confusion.

Must be considered in the very ill person taking metformin, especially if kidney function is impaired.

High mortality rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Lactic acidosis: Investigations

A

blood acidosis (low pH)

low bicarbonate

high serum lactate

absent serum ketones

large anion gap

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lactic acidosis: Treatment

A

Removal of the cause

Rehydration

Alkalinisation with IV sodium bicarbonate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Other diabetes complicactions

A
  1. Erectile dysfunction
    Treatment: Appropriate counselling and (if not taking nitrates) one of the phosphodiesterase inhibitors (Sildenafil), starting with a low dose
  2. Reduced vaginal lubrication with arousal. Tratmement: Lubricants
  3. Postural hypotension
    The usual strict blood pressure targets may need to be relaxed, particularly in the elderly.
    Treatment: Graduated compression stockings & Fludrocortisone.
  4. Gastroparesis
    Treatment options include medication with domperidone, cisapride or erythromycin.
    Injections of botulinum toxin type A into the pylorus via gastroscopy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Practice tips DM

A

Hyperglycaemia is a common cause of tiredness. If elderly people with type 2 diabetes are very tired, think of hyperglycaemia and consider giving insulin to improve their symptoms.

If a person with diabetes (particularly type 1) is very drowsy and looks sick, consider first the diagnosis of ketoacidosis.

Treat associated hypertension with ACE inhibitors or a calcium-channel blocker (also good in combination).

‘Never let the sun go down on pus in a diabetic foot’—admit to hospital.

If a foot ulcer hasn’t healed in 6 weeks, exclude osteomyelitis. Arrange for an MRI and investigate the vasculature (Dolppler).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ABC of diabetes care

A

A: HbA1c <7%
B: BP <140/90
C: Cholesterol <4 mmol/L
Smoking Quit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hypoglycaemia

A

Blood glucose falling below 4.0 mmol/L, although symptoms usually start at <3.5 and become serious at <3.0

Treatment:
In alert patients able to swallow
Give refined carbohydrate orally

Repeat BGL every 15 minutes. If <4, repeat above. If >4, give complex carbohydrate snack or meal (minimum 15 g, e.g. tub of yoghurt, slice of bread, piece of fruit)

Reduced conscious state or unconscious
30 mL 50% glucose slow IV push (instil rectally using the nozzle of the syringe if IV access difficult).
Usually 10 mL in children.
or
1 mL (= 1 ampoule) glucagon IM or SC (0.5 mL in child <25 kg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hormone changes during a critical illness?

A

Increase cortisol, decrease in TSH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Muscle weakness and proximal myopathy (shoulder pain)

A

Hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

absence of headache + anxiety + palpitation + diaphoresis

A

Hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Sinus tachycardia + shortening of the PR interval on ECG

A

Hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

AF on ECG

A

Hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Common symptoms among both hyperthyroidism and hypothyroidism

A

Decreased libido
Psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Hyperthyroidism/Hypothyroidism initial follow up

A

6-8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Hyperthyroidism/Hypothyroidism dose adjustment follow up

A

4-6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

subnormal TSH + normal T3 and T4

A

Subclinical hyperthyroidism (Graves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

auto-antibodies is 90% specific to the diagnosis of Graves disease

A

Anti-TSH receptor antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

↑TSH + ↓T3 and T4

A

Hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

↑TSH + normal T3 and T4

A

Subclinical hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Subclinical hypothyroidism

A

2 thyroid function tests between 12 weeks to confirm diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

↑TSH + ↓T4

A

autoimmune chronic lymphocytic thyroiditis
(Hashimoto’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

most common cause of multinodular goitre

A

Hashimoto’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

unilateral neck swelling without any symptoms

A

Multinodular goitre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Thyroid goitre causes

A

Hashimoto thyroiditis
- Graves’ disease
- Familial or sporadic multinodular goitre
- Iodine deficiency
- Follicular adenoma
- Colloid nodule or cyst
- Thyroid cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Thyroid goitre features

A
  • ↑ TSH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Thyroid goitre surgical indications

A
    • Pemberton sign (Puffiness of face on raising arms above the shoulder)
  1. fail to respond to medical therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Thyroid nodule disease Investigaton approach

A
  1. thorough clinical evaluation,
  2. TFT
  3. an US of thyroid gland and FNAC
    biopsy if nodule > 1 cm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Thyrotoxicosis causes

A
  1. Graves 70%
  2. Toxic multinodular goitre 15%
  3. Toxic adenoma 5%
  4. Thyroiditis 5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Thyrotoxicosis symptoms

A

Weight loss (weight gain in 10%)
- Heat intolerance
- Palpitations
- Breathlessness
- irritability/insomnia
- Tiredness/lethargy
- Diarrhoea
- fine tremor
- sweating, tachycardia
- alopecia
- pretibial myxoedema
- wide pulse pressure
- eye changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Glucagon-like-peptide receptors agonists

A

– Stimulate glucose-mediated insulin secretion
– Suppress glucagon secretion
– Delay gastric emptying
– Decreased appetite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Treatment depends on Ca 2+

A

Rehydration
Bisphophonate
Calcitonin
Steroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

common causes of hypercalcemia

A

Primary hyperparathyroidism and malignancy ( not Secondary)
- Sarcoidosis/Tb
– Malignancies like lymphoma, leukaemia. – Hyperthyroidism.
– Vitamin D overdose.
- Men
- Lithium therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

rare causes of hypercalcemia

A
  • familial benign hypercalceriuc Hypercalcaemia ( low 24 h urinary calcium excretion)
  • SCC lung ( ectopicproduction of PTHrP)
  • Thyrotoxicosis( Osteoclast high)
  • Sarcoidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Primary hyperparathyroidism should undergo parathyroidectomy

A
  • age < 50 years
  • markedly elevated urine calcium excretion
  • kidney stones on radiography
  • decreased creatinine clearance,
  • markedly elevated calcium or one episode of life-threatening hypercalcemia,
  • substantially decreased bone mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

hypercalcemia in malignancy

A
  • symptomatic for hypercalcaemia (Fatigue.
    Bone pain.
    Headaches.
    Nausea and vomiting.
    Constipation etc)
  • usually higher calcium concentrations
51
Q

hypercalcemia in primary hyperparathyroidism

A
  • undetectable or very low PTH
52
Q

MEN Syndrome 1

A
  1. Pituitary adenoma
  2. Parathyroid hyperplasia
  3. Pancreatic tumours
53
Q

MEN Syndrome 2A

A
  1. Parathyroid hyperplasia
  2. Pheochromocytoma
  3. Medullary thyroid carcinoma
54
Q

MEN Syndrome 2B

A
  1. Mucosal neuromas
  2. Marfanoid body habitus
  3. Medullary thyroid carcinoma
  4. Pheochromocytoma
55
Q

headache + palpitation + diaphoresis + elevated serum metanephrines

A

Pheochromocytoma

56
Q

Pheochromocytoma

A
  • episodes
    -Anxiety like (ddx)
  • adrenal gland tumour
  • sympathetic stimulation
  • hypertension
  • ↑ serum epinephrine/metanephrine
  • hypercalcaemia
  • hyperglycaemia
  • erythrocytosis
57
Q

physiological gynecomastia

A
  1. Neonatal gynecomastia= resolves by 1 year of life
  2. pubertal = at 10years age , peak btwn 13-14yrs, disapperas by 17yrs of age
  3. Adults btwn 50-80yrs age
58
Q

Pathologic causes of gynecomastia

A

Rule out:
- Steroid abuse
- Hypogonadism
- Chronic liver or renal disease
- Hyperthyroidism
- Testicular and adrenal tumours
- malnutrition
- Hyperprolactaemia

25% cases are idiopathic gynecomastia

59
Q

Persistent pubertal gynecomastia

A
  • present beyond 17yrs of age
  • not resolving after 2 years
60
Q

Drugs causing gynecomastia

A

Methyldopa
Flutamide, Finasteride
Ketoconazole

Digoxin
Isoniazid
**Spironolactone*
Cimetidine, cyproterene acetate
Omeprazole, Oestrogen
Anabolic steroids

61
Q

B/L parotid enlargement + gynecomastia+ alcohol intake

A

suspect alcoholic liver disease

62
Q

Asymptomatic Pubertal gynecomastia

A

Dont require evaluation
follow up in 6months

63
Q

Gynecomastia >5cm

A

Macromastia

64
Q

Gynecomastia for futher evaluation

A
  • Macromastia
  • Tender, recent onset, progressive/ unknown malignancy
  • concerned Ca testis or non breast malignancies
    -lump irregular, stony hard, fixed, wt loss, loss appetite, nipple chages
65
Q

4 features of gynecomastia

A

symmetrical shape, tender on palpation, central, B/L

66
Q

H/o Non proliferative breast lesions in a female (FIbrocystic diseases)

A

No risk of Ca breast

67
Q

Foot ulcers

A

Peripheral neuropathy
Pph vascular disease
Infections

68
Q

diabetic foot ulcers step-wise approach

A

1-Debridement
2-Wound swabs
3- Antibiotics
4- Imaging (X-ray for osteomyelitis)

69
Q

Foot ulcers treatment

A

uninfected: daily wet dressing, no abs required

Mild infection:
-Oral Amoxicillin + clavulanate
- Cephalexin + metronidazole (penicillin
allergy)
- Ciprofloxacin + clindamycin or lincomycin

Moderate:
- dicloxacillin/flucloxacillin
- + Metronidazole if discharge odorous

Severe:
- Piperacillin + Tazobactam
- Ticarcillin + clavulanate or (if penicillin allergic)
- Ciprofloxacin + either clindamycin or lincomycin

70
Q

Autonomic diabetic neuropathy

A

Dry skin
bright lights sensitivity
urine incontinence
constipation
diarrhea
Erectile dysfunction
Orthostatic hypotension, tachy, brady
fainting

71
Q

Personal history of benign thyroid diseases

A

increased Risk of thyroid cancer

72
Q

Family risk history of benign thyroid diseases

A

No Risk of thyroid cancer

73
Q

Pt on adequate doses of bisphosphonates + 2 minimal trauma #

A

change drug
- Teriparatide

74
Q

BMD T-score <-1.5 + minimal risk fractures

A

osteoporosis

75
Q

T-scores between -1 to -2.5

A

osteopenia

76
Q

AT score of -1

A

normal

77
Q

Osteoporosis treatment

A
  • Alendronate, risedronate and zoledronic acid: first-line therapy in **postmenopausal osteoporosis **
    and prevent vertebral, Non-vertebral and hip fractures.
  • bisphosphonates: primary prevention of fractures in px who never had minimal trauma fracture, secondary prevention of fractures
  • Strontium ranelate: primary prevention of osteoporosis in women
  • bisphosphonates and raloxifene: secondary prevention of fractures in women who have had minimal trauma fractures
  • Strontium ranelate for severe osteoporosis or those with minimal trauma fractures while on adequate dose of bisphosphonates.
78
Q

Osteoporosis treatment not going to plan, what to do

A
  • BMD T-score of =<-2.5
  • > 1 symptomatic new
    fracture after at least 12-months of
    continuous therapy
  • > 2 minimal trauma fractures despite being on sufficient doses of bisphosphonates.

switch to teriparatide for 18 months

79
Q

Males fracture post-op management

A
  • routine biochemical tests for renal or hepatic disease, a full blood count (FBC), serum testosterone,
    calcium, alkaline phosphatase, 25-
    hydroxyvitamin D, and 24-hour urine cortisol.
  • Supplement deficiency related to above results
80
Q

most common cause of pathologic fractures

A

Osteoporosis
- start bisphosphonates

81
Q

hip fracture surgery are in the highest risk for

A

venous thromboembolism (VTE)

82
Q

Anticoagulation for post-surgery

A

1st line: LMWH 12 hours after the surgery up to 35 days
- Warfarin id px desires

83
Q

persistent hypotension + hyperpigmentation + hyponatremia + hyperkalaemia

A

Aldosterone/adrenal insufficiency (Addison’s)

84
Q

Aldosterone/adrenal insufficiency management

A

Known dx: parenteral administration of corticosteroids (Hydrocortisone)
Previous dx:
dexamethasone

85
Q

Weight gain + menstrual irregularities + Hypertension + Hyperglycaemia + Proximal muscle weakness

A

Cushing syndrome

86
Q

Cushing syndrome causes

A

exogenous steroids (rheumatic diseases, SLE, RA)

87
Q

Cushing syndrome investigation

A

24-hour urine cortisol level

88
Q

Cushing syndrome treatment

A

surgery

89
Q

thyroidectomy consequence

A

hypocalcaemia

90
Q

Prolactin < 5000 mU/L

A

Hyperprolactinemia due to antipsychotic (risperidone)

91
Q

Prolactin > 5000 mU/L

A

Prolactinoma

92
Q

tall stature + small testes + small penis + gynecomastia + decreased facial and axillary hair growth + decreased libido

A

Klinefelter syndrome (chromosome 47 XXY
abnormality)

93
Q

Klinefelter syndrome complications

A

-Breast tumours.
-Thromboembolic disease.
-Obesity.
-Type II diabetes mellitus.
-Varicose veins
-Learning disabilities

94
Q

most common cause of the pubertal delay

A

constitutional delay of growth and
puberty (CDGP).

95
Q

Severe hypertension resistant to 3 antihypertensive drugs + Hypokalaemia + Adrenal mass/A family history of early onset hypertension or cerebrovascular events less than 40 years

A

Primary aldosteronism (Conn’s)

96
Q

Primary aldosteronism (Conn’s) investigation

A

aldosterone-renin ratio

97
Q

How to differentiate Conn’s from RAS

A

CHECK Renin
Conn’s: low
RAS: high

98
Q

Unilateral RAS treatment

A

ACEi

99
Q

Bilateral RAS treatment

A

Ca Blocker

100
Q

Adult + frontal bossing + increased hand and foot size + mandibular
enlargement + widened space between the lower incisor teeth +
characteristic coarse facial features, + large fleshy nose

A

acromegaly

101
Q

acromegaly investigation

A

Insulin-like growth factor supressed
Perform OGTT

102
Q

SLE screening

A

ANA

103
Q

SLE confirmation

A

dsDNA

104
Q

Endocrinal drugs that are teratogenic

A

1st sem:
- carbimazole
- methimazole
*switch to PTU
2nd sem:
- propylthiouracil
*switch to carbimazole

105
Q

Post op fever on 1st day

A

Pulmonary atelectasis

106
Q

Post op hyponatremia

A

SIADH

107
Q

thyroid tumours are most commonly associated with
autoimmune thyroiditis?

A

Thyroid lymphoma

108
Q

Pituitary disorders

A
  • Pituitary tumor
  • Hyperprolactaemia
  • Acromegaly
  • Diabetes insipidus and SIADH
  • Hypopituitarism
109
Q

Pituitary Adenomas - Presentation

A
  • Benign adenomas (Prolactinoma- most common)
  • Hormon deficiency
  • Hypersecretory Syndromes (Prolactin, GH, ACTH)
  • Local tumor mass symptoms (headache, visual field loss, raised ICP)
110
Q

Pituitary Adenomas - Microadenoma (< 1cm)

A
  • Review (MRI)
111
Q

Pituitary Adenomas - Macroadenoma (> 1cm)

A
  1. without symptoms
    review: MRI
  2. +neurological Symptoms or visual field defects
    Neurosurgery ( transphenoidal), Radiation, Hormonal Replacement
112
Q

Hyperprolactaemia - Cause

A
  • Pituitary adenoma (micro/macro)
  • Pituitary stalk damage
    (1. compressing- Mass/Tumor
    1. Infitration - Sarcoidosis
    2. Stalk section - Head injury, surgery)
  • Drugs (antipsychotics, antidepressant, Metoclorpamide, cimetidine, oestrogen, opiats, Marijuana)
    Pysiological (pregnancy/breastfeeding)
113
Q

Hyperprolacataemia - Presentation

A
  • general: headache, bitemporal hemianopia, reduced libido
  • Female : galactorrhoe, amenorrhoe/oligomenorrhoe
  • Male: hypogonadism, reduced facial hair, erectile dysfunction
114
Q

Hyperprolacataemia- Investigation

A
  • Prolactin level

norm <400 mU/L
Prolactinoma >5000 mU/L
DD think of other cause < 5000mU/L

  • MRI (best investigation)
115
Q

Hyperprolacataemia- Management & complication

A
  1. Dopamin agonist (Bromocriptin, Cabergoline)
  2. Surgery (transphenoidal)
  3. Complication of Surgery DI or Hypopituitarism
116
Q

Acromegaly - Association

A
  • Diabetes
  • Sleep apnoe
  • Carpal tunnel syndrome
  • Arthritis
  • Increased risk for colon cancer
  • Hypertrophic cardiomyopathy
117
Q

Acromegaly - Presentation

A
  • thickened sof tissue (plams,foot)
  • sweating, frontal blossing, thick greasy skin
  • large bones, deep voice
  • Hypertension
  • Osteoarthritis
118
Q

Nehlson Syndrom

A

development of an ACTH-producing pituitary tumour after the surgical removal of both adrenal glands due to a lack of cortisol and negative feedback.
- skin pigmentation (high ACTH)
- bitemporal hemianopia
- lack of other pituitary hormones

119
Q

Acromegaly test

A

IGF 1
Best oral glucose tolerance test (OGTT) with serial GH

120
Q

gynaecomastia

A
121
Q

myxedoma Coma

A
  • High mortality
  • Emergency
  • decreased mental status
  • hypothermia
  • slowing down functions
122
Q

myxedoma Coma cause

A
  • severe longstanding Hypotension
    infection
    myocardial infarction
    cold exposure
    sedetative drugs (opioids)
123
Q

myxedoma Coma treatment

A

t4 intravenous
corticosteroid
supportive care
oral T4 if stable
NG tube

124
Q
A